Necrotizing Fasciitis

Necrotizing fasciitis is a rare but life-threatening bacterial infection that destroys the soft tissue just beneath the skin — the layer called fascia. It spreads with alarming speed along fascial planes, outrunning the skin changes that alert doctors to its presence, and it can kill within 24–72 hours without emergency surgery. It is sometimes called “flesh-eating bacteria” in the press, a description that, while vivid, undersells the complexity: it is not the skin itself being eaten, but the deep connective tissue, and it may be caused by a mixture of bacteria working together (Type I) or by a single aggressive species like Group A Streptococcus (Type II). The defining clinical teaching — “pain out of proportion to appearance” — captures the deceptive early phase when the patient looks only mildly ill but is already critically so. Treatment is surgical emergency: wide excision of all infected tissue until healthy bleeding margins are reached, combined with broad-spectrum antibiotics and intensive care.

Overview
Epidemiology
Pathophysiology
Clinical Presentation
Diagnosis
Treatment: Surgical Debridement
Antibiotic Therapy
Adjunctive Therapies (IVIG and HBO)
Complications and Recovery
Prevention and Risk Reduction
Research Papers
Connections
Featured Videos

1. Overview

Necrotizing fasciitis (NF) is a bacterial infection of the fascial planes — the sheets of fibrous connective tissue that surround muscles, blood vessels, and nerves beneath the skin. The infection does not merely inflame tissue; it kills it, spreading along fascial planes faster than the visible skin changes that typically guide diagnosis. By the time the characteristic skin discoloration, bullae, or crepitus appear, the infection has often already spread centimeters beyond the visible border.

Type I: Polymicrobial (Mixed) Infection

Type I accounts for approximately 80% of all cases. It is caused by a synergistic mix of bacteria working together: anaerobes (such as Bacteroides, Clostridium, and Peptostreptococcus), facultative anaerobes, enterobacteriaceae (such as E. coli, Klebsiella), and sometimes Group A Streptococcus (GAS). The anaerobes create a low-oxygen environment that the other bacteria exploit; together they produce a polymicrobial synergy that overwhelms local host defenses. Type I predominantly affects the trunk and perineal region and occurs most commonly in patients who are diabetic, immunocompromised, or have chronic illness. Abdominal surgery and bowel perforation are important precipitants. The perineal subtype — Fournier’s gangrene — is a special and particularly feared variant, affecting the scrotum, perineum, and perirectal tissues, with a presentation of rapidly spreading crepitus and systemic toxicity.

Type II: Monomicrobial Infection

Type II accounts for approximately 20% of cases and is caused by a single organism — most commonly Group A Streptococcus (Streptococcus pyogenes) or, less often, community-acquired MRSA (Staphylococcus aureus). Unlike Type I, Type II can strike younger, otherwise healthy patients, often following what seems like trivial trauma: a minor cut, a blister, a bruise, a muscle strain, or even no discernible wound at all. It tends to affect the extremities and is frequently complicated by streptococcal toxic shock syndrome (STSS), where bacterial superantigens trigger a massive immune response that drives rapid organ failure. The combination of NF and STSS carries the highest mortality of any NF presentation.

Fournier’s Gangrene

Fournier’s gangrene is perineal NF — a distinct clinical subtype named for the French venereologist Jean Alfred Fournier, who described rapidly progressive scrotal gangrene in young men in 1883. It is almost always polymicrobial (Type I), arising from colonic, urethral, or skin flora. Despite the historical male association, it can occur in women (vulvar/perineal involvement). Scrotal edema, crepitus, and a fouled odor in a systemically ill patient are the hallmarks. The testes are typically spared (they have a separate blood supply from the spermatic cord rather than the perineal fascial planes) — an important surgical consideration during debridement.

2. Epidemiology

Necrotizing fasciitis is a rare but not vanishingly uncommon infection. The CDC estimates approximately 1,000 cases per year in the United States, though this is likely an undercount given variable reporting and diagnostic attribution. The overall mortality rate in published series ranges from 20 to 40%, making it one of the most lethal of all bacterial skin and soft tissue infections. Even with optimal care in tertiary-care centers, one in four patients dies.

The epidemiological profile differs strikingly between types:

Type I (polymicrobial) predominantly affects older adults, patients with diabetes mellitus (which impairs both vascular supply and immune surveillance in the soft tissues), chronic kidney disease, liver cirrhosis, peripheral vascular disease, morbid obesity, and patients on immunosuppressive therapy. Abdominal and colorectal surgery, including bowel perforation, diverticulitis, and perirectal abscess, are important precipitants. Mortality in Type I NF averages 20–30% in most series.
Type II (monomicrobial GAS) is a striking epidemiological outlier in that it disproportionately affects younger, previously healthy people. GAS NF following minor trauma in a healthy person in their 30s or 40s is one of infectious disease’s most alarming presentations precisely because there is no obvious host-defense failure to explain it. The virulence of the GAS strain — particularly M-types 1 and 3 and the presence of certain pyrogenic exotoxin genes — is the dominant driver. Mortality in Type II GAS complicated by STSS can exceed 50%.
Intravenous drug users (IVDU) are a disproportionately affected population, particularly for Type I NF at injection sites. “Skin-popping” (subcutaneous or intramuscular injection) introduces mixed skin and environmental flora into soft tissue, and concomitant immunosuppression from HIV or hepatitis C compounds risk.
Surgical wound dehiscence and contamination is a recognized but uncommon precipitant, particularly following gastrointestinal surgery.
There is a slight male predominance in most series, partly explained by the male predominance of Fournier’s gangrene and occupational/recreational wound exposures. NF occurs across all geographic regions.

3. Pathophysiology

Understanding why NF is so lethal requires understanding why fascia is uniquely vulnerable and why the bacteria spread so fast.

Fascial vulnerability

Fascia is poorly vascularized connective tissue. Unlike skin and muscle, which have rich capillary networks that bring immune cells rapidly to sites of infection, fascia contains few blood vessels. Once bacteria establish a foothold in the fascial plane, the immune response is sluggish. Neutrophils and macrophages cannot arrive in large numbers quickly. The bacteria spread along fascial planes — which are anatomically continuous for large distances — faster than the immune response can contain them.

Anaerobic synergy and gas production

In Type I NF, facultative organisms deplete local oxygen, creating conditions that allow strict anaerobes to proliferate. Anaerobic metabolism produces hydrogen, nitrogen, and methane as metabolic byproducts — gases that accumulate in the fascial plane and are detectable clinically as crepitus (a crackling sensation on palpation) or on imaging as gas in the soft tissues. The presence of gas in a soft tissue infection is a near-pathognomonic sign of NF and demands immediate surgical exploration.

Toxin-mediated destruction in Type II GAS

Group A Streptococcus produces a devastating arsenal of virulence factors. The most clinically important are the streptococcal pyrogenic exotoxins (SPE) A, B, and C — proteins that function as superantigens. Unlike ordinary antigens, which activate only the small fraction of T cells with the right receptor, superantigens bind outside the normal T-cell receptor antigen-binding groove and activate enormous numbers of T cells non-specifically — up to 20–30% of all circulating T cells. This triggers a massive cytokine storm (TNF-alpha, IL-1, IL-6, IFN-gamma) that drives the systemic inflammatory response of streptococcal toxic shock syndrome: fever, hypotension, multi-organ failure. SPE-B is also a protease that directly degrades host tissue proteins and inactivates immune mediators.

Clostridial toxins

When Clostridium species are present (particularly in Type I or in post-traumatic gas gangrene), additional mechanisms apply. C. perfringens alpha-toxin (lecithinase/phospholipase C) destroys cell membranes directly, causing myonecrosis and hemolysis. This is distinct from the nerve-targeted toxins of C. tetani; clostridial NF is a tissue-destroying infection.

Microvascular thrombosis and nerve destruction

Bacterial endotoxins from gram-negative organisms and the massive cytokine release activate the coagulation cascade, causing microvascular thrombosis in the small vessels supplying the fascial planes and overlying skin. This creates zones of ischemia that spread ahead of the visible infection, explains why skin that appears intact overlying NF may already be dying, and creates the terminal sequence: tissue ischemia → nerve destruction → skin anesthesia. The paradox is that loss of pain in a previously painful region is an ominous late sign — the nerve fibers have been destroyed by ischemia, meaning the tissue is dead or dying. A patient who stops complaining of pain in a region of NF has not improved; they have worsened.

4. Clinical Presentation

NF is notorious for a deceptive early phase that looks far less dangerous than it is, followed by a late phase that is unmistakably catastrophic. Recognizing the transition is the central challenge of management.

Early presentation: deceptively mild

The first signs of NF can mimic ordinary cellulitis: erythema (redness) of the skin, edema (swelling), and warmth. The critical distinguishing feature is the intensity and character of pain. The teaching aphorism “pain out of proportion to appearance” captures it: the patient looks mildly ill, the skin looks like a moderate cellulitis, but the patient is writhing, requiring substantial opioid analgesia, and appears far more distressed than the skin findings alone would justify. Fever is usually present. Importantly, the area of tenderness extends beyond the area of visible erythema — palpating at the margin of visible erythema elicits pain, because infection has already spread into the tissue that looks normal. This discordance between skin appearance and pain extent is the earliest reliable clinical clue.

Late and ominous signs

Skin color change: the erythema evolves to a dusky gray, purple, or bronze discoloration, indicating underlying tissue death and vascular compromise.
Hemorrhagic bullae: blisters filled with dark, blood-tinged fluid form as the subcutaneous tissues necrose and fluid tracks upward to the dermis.
Crepitus: palpation of the affected area produces a crackling, rice-crispy sensation from gas in the fascial planes. When present, crepitus is essentially pathognomonic for NF or gas gangrene and mandates immediate surgical exploration.
Skin necrosis: full-thickness skin death, appearing as black or dark leathery patches, indicates late-stage disease. The skin over the infection has been rendered ischemic from below.
Skin anesthesia: as described above, loss of sensation in the affected skin is a paradoxically ominous sign. The patient no longer complains of pain in an area that was previously extremely painful because the nerves are dead.
Septic shock: hypotension, tachycardia, altered mental status, and end-organ dysfunction may accompany or precede the local skin findings, particularly in Type II GAS with STSS.

Fournier’s gangrene presentation

Patients with Fournier’s gangrene present with scrotal or perineal swelling that may initially appear to be a simple scrotal abscess or cellulitis. The key differentiating features are crepitus on palpation of the scrotum or perineum, a foul, distinctive odor (from anaerobic metabolism), rapid progression of erythema to necrosis over hours, and profound systemic toxicity disproportionate to the apparent wound size.

Type II GAS presentation

Type II GAS NF often begins with pain at a site of minor or even invisible trauma. A patient may notice a sore spot after bumping a table or following a muscle strain. Within 24 hours the pain escalates dramatically, the area becomes swollen and erythematous, and systemic toxicity (high fever, rigors, hypotension) develops rapidly. The concurrent development of streptococcal toxic shock syndrome — hypotension plus two or more organ failures in the setting of invasive GAS infection — is a feature of this type and drives its high mortality.

5. Diagnosis

Clinical suspicion is paramount and should never await confirmatory laboratory or imaging results when NF is seriously suspected. A patient who is going to need surgery should go to the operating room based on clinical grounds, not on a score or a scan.

LRINEC Score

The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score, developed by Wong et al. (2004, PMID 15243890), uses six routine laboratory values to stratify risk:

C-reactive protein (CRP) >150 mg/L → +4 points
White blood cell count >25 × 10³/μL → +2 points; 15–25 → +1 point
Hemoglobin <11 g/dL → +2 points; 11–13.5 g/dL → +1 point
Sodium <135 mEq/L → +2 points
Creatinine >1.6 mg/dL → +2 points
Glucose >180 mg/dL → +1 point

A score ≥6 is considered high risk, with a positive predictive value (PPV) of 92% and a negative predictive value (NPV) of 96% in the original cohort. However, the LRINEC score is not a gatekeeper: it should not delay surgical exploration in a patient with compelling clinical features. Early NF can present with a low LRINEC score, particularly if the patient presents before the full inflammatory response is reflected in laboratory values. The score is best used as a confirmatory tool or to raise suspicion in ambiguous presentations.

CT Scanning

CT of the affected area is the best non-invasive imaging modality for suspected NF. Findings that are highly suggestive include: gas within the fascial planes (near-pathognomonic when present, though absent in 25% of cases), asymmetric fascial thickening, fluid tracking along fascial planes, and asymmetric fascial enhancement on contrast imaging. CT should not delay surgical exploration in a rapidly deteriorating patient, but in a patient with an ambiguous clinical picture, it can confirm the diagnosis and delineate the extent of disease to guide surgical planning.

MRI

MRI is the most sensitive imaging modality for detecting early fascial involvement and has excellent soft-tissue contrast. However, it is largely impractical in the acutely ill NF patient: the scan takes longer, patients in septic shock or extreme pain cannot hold still in the scanner, and the time involved may critically delay surgery. MRI has its greatest role when NF is suspected but the patient is stable enough to wait.

Bedside Ultrasound

Point-of-care ultrasound can rapidly detect gas in soft tissues (appearing as dirty shadowing artifacts) and fluid collections along fascial planes. It is fast, available at the bedside, and does not require patient transport. In experienced hands it is a useful adjunct in the emergency evaluation, particularly in unstable patients.

The Finger Test

Surgical exploration under local anesthesia (the “finger test” or “probe test”) can be performed in the emergency department for equivocal cases. A small incision is made down to the fascia at the site of suspected NF. A positive test — the fascia separates easily with no resistance (“lack of tissue resistance to blunt probing”), there is grayish necrotic tissue or no bleeding at the fascial plane, and the tissue has a classic “dishwater” exudate — mandates immediate transfer to the operating room for formal debridement. A negative test (normal tissue resistance, red bleeding edges) argues against NF, though does not exclude it with certainty.

6. Treatment: Surgical Debridement

Surgery is the only definitive treatment for necrotizing fasciitis. Time to the operating room is the single most modifiable determinant of mortality. Every hour of delay between presentation and surgical debridement is associated with increased mortality. The study by McHenry et al. (PMID 17416758) and subsequent series have consistently demonstrated this relationship: patients who reach the OR within 12 hours have dramatically better survival than those who undergo debridement after 24 hours.

Extent of debridement

The goal of surgical debridement is radical and uncompromising: excise all infected, necrotic, or non-viable tissue until bleeding, healthy margins are encountered on all sides. The surgeon must not be reassured by skin that appears normal overlying the debridement field — the infection may already have spread beyond what is visible. The guiding principle is that it is better to remove too much than too little. Margins that “look healthy” must actually bleed freely; pale, gray, or avascular tissue must come out. Sparing tissue to preserve cosmesis or function at the initial debridement is a fatal mistake.

Return to the operating room

NF surgery is not a single operation. Patients are returned to the operating room at 24–48 hour intervals (“second look,” “third look”) until the surgeon is certain that all infected tissue has been removed and clean, viable margins are present at every border. Infection can advance even after an apparently adequate debridement, particularly in immunocompromised patients. No wound is closed primarily after a first debridement in NF; wounds are left open and inspected.

Wound management between debridements

Negative pressure wound therapy (NPWT) — wound VAC systems — are widely used to manage the large open wounds left after NF debridement. NPWT removes excess exudate, reduces bacterial load, promotes granulation tissue formation, and protects the wound from environmental contamination. It allows wound management without daily dressing changes that would be traumatic and resource-intensive for such large defects.

Fournier’s gangrene: surgical specifics

Debridement of Fournier’s gangrene involves radical excision of all affected perineal and scrotal tissue. Orchiectomy is rarely required because the testes receive their blood supply from the spermatic cord (from the aorta and renal vessels), which is separate from the perineal fascial blood supply; the testes are typically viable even when the scrotum is completely debrided. A diverting colostomy may be required if there is perirectal involvement or to prevent fecal contamination of the wound during healing.

Skin grafting and reconstruction

After multiple debridements confirm clean margins and granulation tissue begins to form (typically 2–4 weeks after the initial surgery), split-thickness skin grafting is performed to close the large open wounds. Perineal reconstruction after Fournier’s gangrene is a specialized undertaking, sometimes involving plastic surgery. Full reconstruction may require months and multiple procedures.

7. Antibiotic Therapy

Antibiotics are adjunctive to surgery in NF — they cannot cure NF without debridement, because the infected tissue has no blood supply to deliver antibiotics to the bacteria. However, they suppress systemic bacteremia, reduce toxin production (particularly important for GAS), and treat infection that extends beyond the surgically accessible tissue at the margins.

Empiric broad-spectrum regimen

Because NF may be polymicrobial or caused by an unknown single organism at presentation, empiric therapy must cover:

Gram-positive organisms including MRSA: vancomycin (or daptomycin if vancomycin cannot be used).
Gram-negative and anaerobic organisms: piperacillin-tazobactam (which has broad gram-negative and anaerobic coverage) or, alternatively, a carbapenem (meropenem, imipenem) for high-risk patients or where resistance is a concern. Metronidazole may be added explicitly for anaerobic coverage in some centers.

A typical empiric regimen is: vancomycin + piperacillin-tazobactam ± metronidazole, initiated immediately on clinical suspicion and continued until cultures guide de-escalation.

The critical role of clindamycin for GAS

When GAS Type II NF is suspected or confirmed, clindamycin must be added to the regimen even though GAS is uniformly susceptible to penicillin. The reason is mechanistic: clindamycin is a protein synthesis inhibitor (binds the 50S ribosomal subunit) and therefore suppresses the production of GAS’s destructive toxins — including the streptococcal pyrogenic exotoxins that drive toxic shock. Penicillin kills bacteria but does not stop toxin production; rapidly dividing bacteria make more toxin even as they die. Beta-lactams (penicillin, ampicillin) may be less effective against GAS at high bacterial inocula due to the “Eagle effect” (stationary-phase bacteria downregulate penicillin-binding proteins). The validated regimen for confirmed Type II GAS NF is therefore: penicillin G + clindamycin.

De-escalation

Once wound and blood cultures return with specific organism and sensitivity data (typically 48–72 hours), the antibiotic regimen should be de-escalated to the narrowest effective spectrum. Duration of antibiotic therapy is typically continued until the patient has been systemically well for 48–72 hours and wound cultures are negative, generally 10–14 days total but guided by clinical course.

Antifungal therapy

In immunocompromised patients (transplant recipients, patients on high-dose steroids, prolonged ICU course), fungal involvement (most commonly Candida species) should be considered if the patient is not responding as expected to antibacterial therapy. Empiric antifungal therapy with micafungin or another echinocandin is appropriate while cultures are pending in this population.

8. Adjunctive Therapies: IVIG and Hyperbaric Oxygen

Intravenous Immunoglobulin (IVIG) for Streptococcal Toxic Shock

IVIG contains pooled antibodies from thousands of donors, including antibodies that can neutralize streptococcal pyrogenic exotoxins. By binding and inactivating these superantigens before they can activate T cells, IVIG can theoretically interrupt the cytokine storm of streptococcal toxic shock syndrome (STSS).

The best clinical evidence comes from Kaul et al. (1999, PMID 10080844), published in the New England Journal of Medicine: a matched observational study suggesting a significant mortality reduction with IVIG in patients with severe invasive GAS disease including STSS. A subsequent small randomized controlled trial (Darenberg et al., 2003) also suggested benefit, though it was underpowered. A large European randomized controlled trial (the INSTINCT trial) was conducted but yielded inconclusive results due to early termination.

Current position: IVIG is recommended by most major infectious disease guidelines for Type II GAS NF complicated by streptococcal toxic shock syndrome. The standard dosing is 1–2 g/kg intravenously over 2 days (some protocols use 2 g/kg as a single infusion). IVIG is not indicated for Type I polymicrobial NF in the absence of STSS.

Hyperbaric Oxygen (HBO)

Hyperbaric oxygen therapy delivers 100% oxygen at pressures above atmospheric (typically 2–3 atmospheres absolute), raising tissue pO⊂2; to levels that are directly bactericidal to obligate anaerobes and are theorized to promote wound healing and immune cell function.

The theoretical rationale for HBO in NF is compelling: kill anaerobes, improve tissue oxygenation at wound margins, enhance phagocytic killing by neutrophils (which use reactive oxygen species). However, there are no level-1 randomized controlled trial data demonstrating a mortality benefit for HBO in NF. The existing evidence consists of observational series and small cohort studies, many with significant selection bias (sicker patients often do not receive HBO). Most major guidelines do not mandate HBO as standard of care, noting that the evidence is insufficient to make a strong recommendation.

The most important practical point: HBO must never delay surgical debridement. If an HBO chamber is 30 minutes away and the OR is available now, the patient goes to the OR. HBO, if used, is an adjunct after the primary surgical and antibiotic treatment has been initiated. The logistical challenges of transporting an unstable, ventilated patient to an HBO chamber further limit its applicability in the most critically ill patients.

9. Complications and Recovery

Acute complications

Septic shock: present or develops in the majority of patients with NF, often requiring vasopressor therapy and ICU-level care.
Acute kidney injury (AKI): from septic shock, direct toxin effects, myoglobinuria from muscle destruction, and nephrotoxic antibiotics; may require renal replacement therapy.
Respiratory failure: from sepsis-associated acute respiratory distress syndrome (ARDS), aspiration, or pulmonary edema; may require mechanical ventilation for days to weeks.
Disseminated intravascular coagulation (DIC): particularly common in GAS NF with STSS; presents with simultaneous bleeding and clotting and carries high mortality.
Hepatic failure: from sepsis and direct toxin effects.

Surgical complications

Amputation: required in 15–30% of limb NF cases where the extent of tissue destruction precludes limb salvage or where ongoing infection cannot be controlled without removing the extremity. Amputation is a life-saving procedure in these cases, not a failure of management.
Sexual dysfunction following Fournier’s gangrene debridement: generally rare when the testes are preserved; penile skin loss may require reconstruction but function is often maintained.
Prolonged wound care: the large open wounds left by radical debridement require weeks to months of dressing changes, NPWT, and ultimately skin grafting or reconstructive surgery.

Long-term recovery

Recovery from NF is prolonged and demanding. Patients who survive the acute phase face weeks to months of hospitalization, wound care, physical rehabilitation, and reconstruction. Post-traumatic stress disorder (PTSD) is common: the experience of being critically ill, undergoing repeated surgeries, waking with large open wounds, and potentially losing a limb is profoundly traumatic. Formal psychological support and psychiatric follow-up are essential components of NF survivorship care. Physical rehabilitation after amputation or after prolonged ICU-related deconditioning requires intensive occupational and physiotherapy. Body-image concerns following disfiguring surgery require psychological support and, where appropriate, reconstructive plastic surgery consultation.

10. Prevention and Risk Reduction

Necrotizing fasciitis cannot be reliably prevented in the way that vaccine-preventable diseases can be, because the organisms that cause it are ubiquitous, and the specific combination of host factors and bacterial virulence that produce NF is not predictable. However, several risk-reduction strategies are evidence-informed and practical:

Prompt wound care: clean any break in the skin immediately with soap and running water, irrigate thoroughly, and seek medical attention for wounds that are deep, puncture-type, contaminated with soil or organic material, or sustained in a high-risk environment. This is particularly important for people with diabetes, peripheral vascular disease, or immunosuppression.
Antibiotic prophylaxis for high-risk surgical wounds: standard perioperative prophylaxis with appropriate antibiotics for bowel surgery, colorectal procedures, and other contaminated surgical fields reduces the risk of post-operative soft-tissue infections including NF.
Glycemic control in diabetes: poorly controlled diabetes is a major independent risk factor for NF. Maintaining HbA1c targets reduces immune dysfunction, improves microvascular blood flow, and reduces the risk of soft-tissue infections broadly.
Rapid evaluation of spreading skin infections: any skin infection (erythema, warmth, swelling) that is progressing rapidly, that involves pain out of proportion to appearance, or that is accompanied by systemic symptoms (fever, rigors, hypotension) in a high-risk patient (diabetic, immunocompromised, elderly) should be evaluated urgently — same day, in an emergency department setting.
NSAID use in GAS infections (controversial): there are observational data suggesting that NSAID use in patients with streptococcal skin infections or pharyngitis is associated with higher rates of invasive GAS disease, including NF. The proposed mechanism is that NSAIDs suppress the febrile response and local inflammatory signs that would otherwise prompt earlier recognition and treatment, and may impair neutrophil function. The evidence is observational and not definitive; no randomized trial has addressed this. The practical implication is caution in using NSAIDs as the sole therapy for apparent streptococcal pharyngitis or skin infections, particularly if the patient is not improving rapidly.
IVDU harm reduction: for people who inject drugs, reducing skin-popping practices, using sterile equipment, and accessing wound care services reduces the risk of soft-tissue infections including NF.

11. Research Papers

Key Research Papers

PubMed Research Searches

The following links open live PubMed queries covering the major clinical dimensions of necrotizing fasciitis. Each search opens in a new tab and returns the most current peer-reviewed literature.

Connections

Back to Table of Contents